Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.

Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448.

Bamodu OA, Huang WC, Lee WH, Wu A, Wang LS, Hsiao M, Yeh CT, Chao TY.

BMC Cancer. 2016 Feb 25;16(1):160. doi: 10.1186/s12885-016-2108-5.

2.

Depletion of histone demethylase KDM5B inhibits cell proliferation of hepatocellular carcinoma by regulation of cell cycle checkpoint proteins p15 and p27.

Wang D, Han S, Peng R, Jiao C, Wang X, Yang X, Yang R, Li X.

J Exp Clin Cancer Res. 2016 Feb 25;35:37. doi: 10.1186/s13046-016-0311-5.

3.

Transcriptional Regulation of JARID1B/KDM5B Histone Demethylase by Ikaros, Histone Deacetylase 1 (HDAC1), and Casein Kinase 2 (CK2) in B-cell Acute Lymphoblastic Leukemia.

Wang H, Song C, Ding Y, Pan X, Ge Z, Tan BH, Gowda C, Sachdev M, Muthusami S, Ouyang H, Lai L, Francis OL, Morris CL, Abdel-Azim H, Dorsam G, Xiang M, Payne KJ, Dovat S.

J Biol Chem. 2016 Feb 19;291(8):4004-18. doi: 10.1074/jbc.M115.679332. Epub 2015 Dec 10.

PMID:
26655717
4.

Escape from Mitotic Arrest: An Unexpected Connection Between Microtubule Dynamics and Epigenetic Regulation of Centromeric Chromatin in Schizosaccharomyces pombe.

George AA, Walworth NC.

Genetics. 2015 Dec;201(4):1467-78. doi: 10.1534/genetics.115.181792. Epub 2015 Oct 28.

PMID:
26510788
5.

JARID1B deletion induced apoptosis in Jeko-1 and HL-60 cell lines.

Su H, Ma X, Huang Y, Han H, Zou Y, Huang W.

Int J Clin Exp Pathol. 2015 Jan 1;8(1):171-83. eCollection 2015.

6.

Overexpression of JARID1B is associated with poor prognosis and chemotherapy resistance in epithelial ovarian cancer.

Wang L, Mao Y, Du G, He C, Han S.

Tumour Biol. 2015 Apr;36(4):2465-72. doi: 10.1007/s13277-014-2859-z. Epub 2015 Feb 8.

7.

Impairment of preimplantation porcine embryo development by histone demethylase KDM5B knockdown through disturbance of bivalent H3K4me3-H3K27me3 modifications.

Huang J, Zhang H, Wang X, Dobbs KB, Yao J, Qin G, Whitworth K, Walters EM, Prather RS, Zhao J.

Biol Reprod. 2015 Mar;92(3):72. doi: 10.1095/biolreprod.114.122762. Epub 2015 Jan 21.

8.

Molecular pathways involved in pregnancy-induced prevention against breast cancer.

Barton M, Santucci-Pereira J, Russo J.

Front Endocrinol (Lausanne). 2014 Dec 10;5:213. doi: 10.3389/fendo.2014.00213. eCollection 2014. Review.

9.

MicroRNA-7 inhibits multiple oncogenic pathways to suppress HER2Δ16 mediated breast tumorigenesis and reverse trastuzumab resistance.

Huynh FC, Jones FE.

PLoS One. 2014 Dec 22;9(12):e114419. doi: 10.1371/journal.pone.0114419. eCollection 2014.

10.

Physical and functional interactions between the histone H3K4 demethylase KDM5A and the nucleosome remodeling and deacetylase (NuRD) complex.

Nishibuchi G, Shibata Y, Hayakawa T, Hayakawa N, Ohtani Y, Sinmyozu K, Tagami H, Nakayama J.

J Biol Chem. 2014 Oct 17;289(42):28956-70. doi: 10.1074/jbc.M114.573725. Epub 2014 Sep 4.

11.

Chromatin and oxygen sensing in the context of JmjC histone demethylases.

Shmakova A, Batie M, Druker J, Rocha S.

Biochem J. 2014 Sep 15;462(3):385-95. doi: 10.1042/BJ20140754. Review.

12.

Histone demethylase jumonji AT-rich interactive domain 1B (JARID1B) controls mammary gland development by regulating key developmental and lineage specification genes.

Zou MR, Cao J, Liu Z, Huh SJ, Polyak K, Yan Q.

J Biol Chem. 2014 Jun 20;289(25):17620-33. doi: 10.1074/jbc.M114.570853. Epub 2014 May 6.

13.

The breast cancer oncogene EMSY represses transcription of antimetastatic microRNA miR-31.

Viré E, Curtis C, Davalos V, Git A, Robson S, Villanueva A, Vidal A, Barbieri I, Aparicio S, Esteller M, Caldas C, Kouzarides T.

Mol Cell. 2014 Mar 6;53(5):806-18. doi: 10.1016/j.molcel.2014.01.029. Epub 2014 Feb 27. Erratum in: Mol Cell. 2014 Apr 10;54(1):203. Barbieri, Isaia [added].

14.

Unliganded progesterone receptor-mediated targeting of an RNA-containing repressive complex silences a subset of hormone-inducible genes.

Vicent GP, Nacht AS, Zaurin R, Font-Mateu J, Soronellas D, Le Dily F, Reyes D, Beato M.

Genes Dev. 2013 May 15;27(10):1179-97. doi: 10.1101/gad.215293.113.

15.

Cancer and altered metabolism: potential importance of hypoxia-inducible factor and 2-oxoglutarate-dependent dioxygenases.

Kaelin WG Jr.

Cold Spring Harb Symp Quant Biol. 2011;76:335-45. doi: 10.1101/sqb.2011.76.010975. Epub 2011 Nov 16. Review.

16.

Jarid1b targets genes regulating development and is involved in neural differentiation.

Schmitz SU, Albert M, Malatesta M, Morey L, Johansen JV, Bak M, Tommerup N, Abarrategui I, Helin K.

EMBO J. 2011 Nov 16;30(22):4586-600. doi: 10.1038/emboj.2011.383.

17.

Jumonji/ARID1 B (JARID1B) protein promotes breast tumor cell cycle progression through epigenetic repression of microRNA let-7e.

Mitra D, Das PM, Huynh FC, Jones FE.

J Biol Chem. 2011 Nov 25;286(47):40531-5. doi: 10.1074/jbc.M111.304865. Epub 2011 Oct 3.

18.

Targeting Histone Demethylases: A New Avenue for the Fight against Cancer.

Rotili D, Mai A.

Genes Cancer. 2011 Jun;2(6):663-79. doi: 10.1177/1947601911417976.

19.

Chromatin as an oxygen sensor and active player in the hypoxia response.

Melvin A, Rocha S.

Cell Signal. 2012 Jan;24(1):35-43. doi: 10.1016/j.cellsig.2011.08.019. Epub 2011 Sep 8. Review.

20.

Crystallization and preliminary crystallographic analysis of a PHD domain of human JARID1B.

Guo X, Xu Y, Wang P, Li Z, Xu Y, Yang H.

Acta Crystallogr Sect F Struct Biol Cryst Commun. 2011 Aug 1;67(Pt 8):907-10. doi: 10.1107/S1744309111021981. Epub 2011 Jul 19.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk